Prospective, randomized, controlled trial assessing the effects of a driving pressure-limiting strategy for patients with acute respiratory distress syndrome due to community-acquired pneumonia (STAMINA trial): protocol and statistical analysis plan
STAMINA Study Group Investigators,Israel Silva Maia,Fernando Azevedo Medrado Jr,Lucas Tramujas,Bruno Martins Tomazini,Júlia Souza Oliveira,Erica Regina Ribeiro Sady,Letícia Galvão Barbante,Marina Lazzari Nicola,Rodrigo Magalhães Gurgel,Lucas Petri Damiani,Karina Leal Negrelli,Tamiris Abait Miranda,Eliana Santucci,Nanci Valeis,Ligia Nasi Laranjeira,Glauco Adrieno Westphal,Ruthy Perotto Fernandes,Cássio Luis Zandonai,Mariangela Pimentel Pincelli,Rodrigo Cruvinel Figueiredo,Cíntia Loss Sartori Bustamante,Luiz Fernando Norbin,Emerson Boschi,Rafael Lessa,Marcelo Pereira Romano,Mieko Cláudia Miura,Meton Soares de Alencar Filho,Vicente Cés de Souza Dantas,Priscilla Alves Barreto,Mauro Esteves Hernandes,Cintia Magalhães Carvalho Grion,Alexandre Sanches Laranjeira,Ana Luiza Mezzaroba,Marina Bahl,Ana Carolina Starke,Rodrigo Santos Biondi,Felipe Dal-Pizzol,Eliana Bernadete Caser,Marlus Muri Thompson,Andrea Allegrini Padial,Viviane Cordeiro Veiga,Rodrigo Thot Leite,Gustavo Araújo,Mário Guimarães,Priscilla de Aquino Martins,Fábio Holanda Lacerda,Conrado Roberto Hoffmann Filho,Livia Melro,Eduardo Pacheco,Gustavo Adolfo Ospina-Táscon,Juliana Carvalho Ferreira,Fabricio Jocundo Calado Freires,Flávia Ribeiro Machado,Alexandre Biasi Cavalcanti,Fernando Godinho Zampieri
DOI: https://doi.org/10.62675/2965-2774.20240210-en
2024-05-20
Abstract:Background: Driving pressure has been suggested to be the main driver of ventilator-induced lung injury and mortality in observational studies of acute respiratory distress syndrome. Whether a driving pressure-limiting strategy can improve clinical outcomes is unclear. Objective: To describe the protocol and statistical analysis plan that will be used to test whether a driving pressure-limiting strategy including positive end-expiratory pressure titration according to the best respiratory compliance and reduction in tidal volume is superior to a standard strategy involving the use of the ARDSNet low-positive end-expiratory pressure table in terms of increasing the number of ventilator-free days in patients with acute respiratory distress syndrome due to community-acquired pneumonia. Methods: The ventilator STrAtegy for coMmunIty acquired pNeumoniA (STAMINA) study is a randomized, multicenter, open-label trial that compares a driving pressure-limiting strategy to the ARDSnet low-positive end-expiratory pressure table in patients with moderate-to-severe acute respiratory distress syndrome due to community-acquired pneumonia admitted to intensive care units. We expect to recruit 500 patients from 20 Brazilian and 2 Colombian intensive care units. They will be randomized to a driving pressure-limiting strategy group or to a standard strategy using the ARDSNet low-positive end-expiratory pressure table. In the driving pressure-limiting strategy group, positive end-expiratory pressure will be titrated according to the best respiratory system compliance. Outcomes: The primary outcome is the number of ventilator-free days within 28 days. The secondary outcomes are in-hospital and intensive care unit mortality and the need for rescue therapies such as extracorporeal life support, recruitment maneuvers and inhaled nitric oxide. Conclusion: STAMINA is designed to provide evidence on whether a driving pressure-limiting strategy is superior to the ARDSNet low-positive end-expiratory pressure table strategy for increasing the number of ventilator-free days within 28 days in patients with moderate-to-severe acute respiratory distress syndrome. Here, we describe the rationale, design and status of the trial.